Theratechnologies
THTX
THTX was delisted on the 25th of September, 2025.
33 hedge funds and large institutions have $23.6M invested in Theratechnologies in 2024 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 9 increasing their positions, 7 reducing their positions, and 2 closing their positions.
150% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 2
29% more repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 7
10% more funds holding
Funds holding: 30 → 33 (+3)
17% less capital invested
Capital invested by funds: $28.3M → $23.6M (-$4.73M)
41.17% less ownership
Funds ownership: 72.16% → 30.99% (-41%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
STA
Summit Trail Advisors
New York
|
+$53.1K |
| 2 |
National Bank of Canada
Montreal,
Quebec, Canada
|
+$52K |
| 3 |
Osaic Holdings
Scottsdale,
Arizona
|
+$27K |
| 4 |
Northern Trust
Chicago,
Illinois
|
+$20.6K |
| 5 |
MWM
Modern Wealth Management
Lenexa,
Kansas
|
+$16.8K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
-$3.64M |
| 2 |
WVP
Worth Venture Partners
Fort Lee,
New Jersey
|
-$1.47M |
| 3 |
CWP
Cyndeo Wealth Partners
St. Petersburg,
Florida
|
-$169K |
| 4 |
Bank of Montreal
Toronto,
Ontario, Canada
|
-$44.9K |
| 5 |
PNC Financial Services Group
Pittsburgh,
Pennsylvania
|
-$18.8K |
THTX Hedge Fund Activity: Q1 2024 in Review
33 of the 6,943 institutional investors tracked by Wall St. Rank reported a position in Theratechnologies (THTX) for Q1 2024, worth a combined $23.6M — down 17% from $28.3M a quarter earlier.
Buyers outnumbered sellers: 5 funds opened new THTX positions and 2 closed out — a net gain of 3 holders — while 9 added to existing stakes and 7 trimmed.
The largest buyer was Summit Trail Advisors, opening a new position worth an estimated $53.1K. The largest seller was Morgan Stanley, cutting an estimated $3.64M.
- 33 institutional investors held Theratechnologies (THTX) as of Q1 2024, up from 30 in Q4 2023.
- Funds reported $23.6M of Theratechnologies stock for Q1 2024, down 17% quarter-over-quarter.
- 5 funds opened new Theratechnologies positions in Q1 2024 and 2 closed out, a net change of +3 holders.
- The largest Theratechnologies buyer in Q1 2024 was Summit Trail Advisors, an estimated $53.1K added.
- The largest Theratechnologies seller in Q1 2024 was Morgan Stanley, an estimated $3.64M sold.
Based on aggregated 13F filings for Q1 2024.